Search research articles
Contact Us
Filters
Showing results (191-200 of 324) with videos related to
Page
of 33
Sort By:
Pharmacogenetics and Genomics
|
April 13, 2006
Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir
Mark A Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham, et al.
Plos One
|
October 17, 2013
Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency
Denise C Hsu, Stephen J Kerr, Thatri Iampornsin, et al.
BMC Public Health
|
September 6, 2014
The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: design and methods
Benjamin R Bavinton, Fengyi Jin, Garrett Prestage, et al.
AIDS (London, England)
|
January 9, 2018
Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy
Gwamaka E Mwasakifwa, Cecilia Moore, Dianne Carey, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)
|
March 3, 2007
Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens
Stephen J Kerr, Chris Duncombe, Anchalee Avihingsanon, et al.
The Journal of Infectious Diseases
|
October 17, 2006
Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012)
Mark A Boyd, Narendra M Dixit, Umaporn Siangphoe, et al.
Antiviral Therapy
|
October 29, 2014
Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection
Joseph J Eron, David A Cooper, Roy T Steigbigel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 26, 2010
Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study
Rebekah L Puls, Preeyaporn Srasuebkul, Kathy Petoumenos, et al.
The Journal of Infection
|
December 12, 2013
Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy
Denise C Hsu, Stephen J Kerr, Parawee Thongpaeng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?
John T Lucas, M Beth McCarville, David A Cooper, et al.
Page
of 33
Search research articles
Search
Showing results (191-200 of 324) with videos related to
Sort By:
Page
of 33
Pharmacogenetics and Genomics
|
April 13, 2006
Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir
Mark A Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham, et al.
Plos One
|
October 17, 2013
Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency
Denise C Hsu, Stephen J Kerr, Thatri Iampornsin, et al.
BMC Public Health
|
September 6, 2014
The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: design and methods
Benjamin R Bavinton, Fengyi Jin, Garrett Prestage, et al.
AIDS (London, England)
|
January 9, 2018
Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy
Gwamaka E Mwasakifwa, Cecilia Moore, Dianne Carey, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)
|
March 3, 2007
Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens
Stephen J Kerr, Chris Duncombe, Anchalee Avihingsanon, et al.
The Journal of Infectious Diseases
|
October 17, 2006
Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012)
Mark A Boyd, Narendra M Dixit, Umaporn Siangphoe, et al.
Antiviral Therapy
|
October 29, 2014
Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection
Joseph J Eron, David A Cooper, Roy T Steigbigel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 26, 2010
Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study
Rebekah L Puls, Preeyaporn Srasuebkul, Kathy Petoumenos, et al.
The Journal of Infection
|
December 12, 2013
Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy
Denise C Hsu, Stephen J Kerr, Parawee Thongpaeng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?
John T Lucas, M Beth McCarville, David A Cooper, et al.
Page
of 33